See also this year's filing and all EDGAR filings for this company.
PDF Report 0001348362_2020_Lexaria_Bioscience_Corp.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperations'} |
Graph
Absolute values for 0001348362, Lexaria Bioscience Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,818,829 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 591,263 |
| 3 | remainder_Assets | 265,127 |
| 4 | LiabilitiesCurrent | 184,507 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 23,083 |
| 8 | SellingGeneralAndAdministrativeExpense | 524,628 |
| 9 | ResearchAndDevelopmentExpense | 561,920 |
| 10 | remainder_Expenses | 4,451,275 |
| 11 | remainder_Revenues | 294,512 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -14,246 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,675,219 |
| 1 | Liabilities | 184,507 |
| 2 | Expenses | 5,560,906 |
| 3 | Revenues | 294,512 |
| 4 | StockholdersEquity | 2,490,712 |
| 5 | NetIncome | -5,266,394 |
| 6 | ComprehensiveNetIncome | -5,273,517 |
| 7 | BaseVar | 4,364,695 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.109 |
| 9 | EconomicCapitalRatio | 1.52 |
Edgar->Model Mapping
Feature Distribution
Change over Time
